Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
Cantor Fitzgerald has downgraded Editas Medicine Inc (NASDAQ: EDIT) to Neutral from Overw
Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy
Cantor Fitzgerald has downgraded CRISPR Therapeutics AG (NASDAQ: CRSP) to Neutral from Ov
Benzinga’s Top Ratings Upgrades, Downgrades For October 17, 2023
Upgrades According to Wolfe Research, the prior rating for TC Energy Corp (NYSE:TRP) was changed from Underperform to…
US Residential Solar Demand May Curb Growth Trajectory Of Enphase Energy: Analyst
BMO Capital Markets analyst Ameet Thakkar downgraded Enphase Energy Inc (NASDAQ: ENPH) to Market Perform from Outperform at a
KBH Downgraded: Goldman Sachs Points Out Spike In Cancellation Rates And Debt Concerns
Goldman Sachs analyst Susan Maklari downgraded KB Home (NYSE: KBH) to Neutral from Buy at a lowered
Analyst Favors Exxon Mobil Deal, But Downgrades Pioneer Natural Resources: Here’s Why
BMO Capital Markets analyst Phillip Jungwirth downgraded Pioneer Natural Resources Co (NYSE: PXD) to
Benzinga’s Top Ratings Upgrades, Downgrades For October 16, 2023
Upgrades Scotiabank upgraded the previous rating for Alliant Energy Corp (NASDAQ:LNT) from Sector Perform to Sector Outperform. In…
InMode Faces Revenue Headwinds Amid Challenging Economics: Analyst Cuts Price Target And Estimates
Canaccord Genuity analyst Caitlin Cronin downgraded InMode Ltd (NASDAQ: INMD) to Hold from Buy at a lowered
Is Netflix Losing Its Spark? Analyst Downgrades Amid Sluggish Growth and AVOD Adoption
Wolfe Research analyst Peter Supino downgraded Netflix Inc (NASDAQ: NFLX) from Outperform
Benzinga’s Top Ratings Upgrades, Downgrades For October 13, 2023
Upgrades Northland Capital Markets upgraded the previous rating for SolarEdge Technologies Inc (NASDAQ:SEDG) from Market Perform to Outperform.…